| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (517kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-431922
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.43192
Zusammenfassung
Early relapse of acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an often unsuccessful therapeutic challenge. Since treatment options are few and efficacy is low, new approaches such as de novo allo-HSCT, targeted therapies and biomodulatory drugs have been developed, albeit prognosis is very poor. In this manuscript we present an unusual case ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik